 Donna Bergen
Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 22 | 2015 | 109 | 2.800 |
Why?
| | Anticonvulsants | 14 | 2015 | 110 | 1.410 |
Why?
| | Neurology | 6 | 2014 | 113 | 1.390 |
Why?
| | International Classification of Diseases | 4 | 2015 | 25 | 1.310 |
Why?
| | Nervous System Diseases | 6 | 2014 | 145 | 1.190 |
Why?
| | Seizures | 5 | 2012 | 88 | 0.700 |
Why?
| | International Agencies | 1 | 2015 | 7 | 0.570 |
Why?
| | Hospitals, University | 1 | 2014 | 46 | 0.530 |
Why?
| | Global Health | 3 | 2002 | 60 | 0.500 |
Why?
| | Education, Medical, Graduate | 2 | 2006 | 83 | 0.500 |
Why?
| | Biomedical Research | 1 | 2014 | 89 | 0.490 |
Why?
| | Epilepsy, Temporal Lobe | 7 | 2016 | 48 | 0.470 |
Why?
| | Carbamazepine | 6 | 2004 | 13 | 0.440 |
Why?
| | Cyclohexanecarboxylic Acids | 5 | 2004 | 16 | 0.430 |
Why?
| | Amines | 5 | 2004 | 17 | 0.430 |
Why?
| | gamma-Aminobutyric Acid | 5 | 2004 | 50 | 0.420 |
Why?
| | Humans | 56 | 2016 | 31481 | 0.410 |
Why?
| | Epilepsies, Partial | 7 | 2010 | 24 | 0.410 |
Why?
| | Poverty | 2 | 2008 | 104 | 0.370 |
Why?
| | Pharmacies | 1 | 2008 | 2 | 0.370 |
Why?
| | Cranial Irradiation | 1 | 2008 | 18 | 0.360 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2008 | 14 | 0.360 |
Why?
| | Medication Errors | 1 | 2008 | 20 | 0.360 |
Why?
| | Methotrexate | 1 | 2008 | 47 | 0.360 |
Why?
| | Risk | 1 | 2008 | 228 | 0.340 |
Why?
| | Intellectual Disability | 1 | 2008 | 47 | 0.340 |
Why?
| | Status Epilepticus | 1 | 2008 | 49 | 0.330 |
Why?
| | Antirheumatic Agents | 1 | 2008 | 96 | 0.330 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2008 | 115 | 0.320 |
Why?
| | Child | 15 | 2016 | 1572 | 0.300 |
Why?
| | World Health Organization | 4 | 2014 | 19 | 0.280 |
Why?
| | Electroencephalography | 10 | 2011 | 145 | 0.280 |
Why?
| | History, 21st Century | 2 | 2015 | 39 | 0.270 |
Why?
| | Fructose | 4 | 2004 | 11 | 0.270 |
Why?
| | History, 20th Century | 2 | 2015 | 94 | 0.270 |
Why?
| | Adult | 31 | 2016 | 9779 | 0.260 |
Why?
| | Magnetic Resonance Imaging | 6 | 2016 | 1273 | 0.230 |
Why?
| | Adolescent | 20 | 2016 | 2667 | 0.230 |
Why?
| | Epilepsy, Generalized | 4 | 2004 | 8 | 0.230 |
Why?
| | Acetates | 5 | 2004 | 26 | 0.230 |
Why?
| | Female | 28 | 2016 | 18253 | 0.230 |
Why?
| | Temporal Lobe | 4 | 1998 | 112 | 0.230 |
Why?
| | Cognition | 1 | 2008 | 1206 | 0.190 |
Why?
| | Anterior Thalamic Nuclei | 2 | 2010 | 4 | 0.190 |
Why?
| | Epilepsy, Complex Partial | 1 | 1998 | 7 | 0.180 |
Why?
| | Male | 24 | 2016 | 17583 | 0.180 |
Why?
| | Health Planning | 1 | 1998 | 5 | 0.180 |
Why?
| | Somatoform Disorders | 1 | 1998 | 20 | 0.170 |
Why?
| | Preventive Medicine | 1 | 1998 | 13 | 0.170 |
Why?
| | Fecal Incontinence | 1 | 1997 | 9 | 0.170 |
Why?
| | Drug Industry | 1 | 1997 | 29 | 0.170 |
Why?
| | Public Health | 1 | 1998 | 66 | 0.160 |
Why?
| | Urinary Incontinence | 1 | 1997 | 25 | 0.160 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 2 | 2016 | 84 | 0.160 |
Why?
| | Mental Disorders | 3 | 2014 | 206 | 0.160 |
Why?
| | Landau-Kleffner Syndrome | 1 | 1995 | 4 | 0.150 |
Why?
| | Cerebral Cortex | 2 | 2008 | 206 | 0.150 |
Why?
| | Neurosurgical Procedures | 2 | 2016 | 169 | 0.150 |
Why?
| | Phenobarbital | 1 | 2015 | 5 | 0.140 |
Why?
| | Surgery, Computer-Assisted | 1 | 2016 | 61 | 0.140 |
Why?
| | Drug and Narcotic Control | 1 | 2015 | 8 | 0.140 |
Why?
| | Hemiplegia | 2 | 1992 | 7 | 0.140 |
Why?
| | Propylene Glycols | 1 | 1995 | 4 | 0.140 |
Why?
| | Body Weight | 1 | 1995 | 167 | 0.130 |
Why?
| | Electric Stimulation Therapy | 2 | 2010 | 43 | 0.130 |
Why?
| | Crying | 1 | 1993 | 1 | 0.130 |
Why?
| | Monitoring, Physiologic | 2 | 2008 | 100 | 0.120 |
Why?
| | Societies, Medical | 1 | 2015 | 209 | 0.120 |
Why?
| | Forecasting | 1 | 2013 | 134 | 0.120 |
Why?
| | Isoxazoles | 4 | 2004 | 17 | 0.120 |
Why?
| | Preoperative Care | 2 | 2016 | 146 | 0.110 |
Why?
| | Libido | 1 | 1992 | 8 | 0.110 |
Why?
| | Sexual Dysfunctions, Psychological | 1 | 1992 | 11 | 0.110 |
Why?
| | Postoperative Complications | 2 | 1998 | 1083 | 0.110 |
Why?
| | Child, Preschool | 6 | 2008 | 786 | 0.110 |
Why?
| | Headache | 2 | 2011 | 52 | 0.110 |
Why?
| | Sexual Behavior | 1 | 1992 | 71 | 0.110 |
Why?
| | Hippocampus | 3 | 2011 | 295 | 0.100 |
Why?
| | Middle Aged | 18 | 2016 | 11209 | 0.100 |
Why?
| | Deep Brain Stimulation | 2 | 2010 | 76 | 0.100 |
Why?
| | Implantable Neurostimulators | 1 | 2010 | 14 | 0.100 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2010 | 41 | 0.100 |
Why?
| | Brain Neoplasms | 2 | 1989 | 187 | 0.100 |
Why?
| | Diazepam | 2 | 2001 | 10 | 0.100 |
Why?
| | Triazines | 5 | 2004 | 17 | 0.100 |
Why?
| | Neuroblastoma | 1 | 1989 | 24 | 0.090 |
Why?
| | Astrocytoma | 1 | 1989 | 37 | 0.090 |
Why?
| | Disabled Persons | 2 | 2002 | 119 | 0.090 |
Why?
| | Intelligence | 1 | 2008 | 28 | 0.090 |
Why?
| | Patient Education as Topic | 2 | 2002 | 192 | 0.090 |
Why?
| | Electrodiagnosis | 1 | 2008 | 8 | 0.090 |
Why?
| | Epidural Space | 1 | 2008 | 22 | 0.090 |
Why?
| | Disease Outbreaks | 1 | 2008 | 87 | 0.090 |
Why?
| | Vagus Nerve | 2 | 2000 | 15 | 0.080 |
Why?
| | Drug Interactions | 3 | 2004 | 70 | 0.080 |
Why?
| | Functional Laterality | 3 | 2011 | 96 | 0.080 |
Why?
| | Training Support | 1 | 2006 | 7 | 0.080 |
Why?
| | Societies, Scientific | 1 | 2006 | 12 | 0.080 |
Why?
| | Data Collection | 1 | 2006 | 120 | 0.070 |
Why?
| | Treatment Outcome | 7 | 2015 | 3910 | 0.070 |
Why?
| | Levodopa | 2 | 1975 | 139 | 0.070 |
Why?
| | Antipsychotic Agents | 1 | 2004 | 89 | 0.060 |
Why?
| | Valproic Acid | 2 | 2011 | 32 | 0.060 |
Why?
| | Internship and Residency | 1 | 2006 | 201 | 0.060 |
Why?
| | Specialty Boards | 1 | 2002 | 10 | 0.060 |
Why?
| | International Cooperation | 1 | 2002 | 38 | 0.060 |
Why?
| | Patient Advocacy | 1 | 2002 | 17 | 0.060 |
Why?
| | Urban Health | 1 | 2002 | 29 | 0.060 |
Why?
| | Cost of Illness | 1 | 2002 | 65 | 0.060 |
Why?
| | Tourette Syndrome | 1 | 1982 | 46 | 0.060 |
Why?
| | Brain | 3 | 2008 | 1655 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2016 | 637 | 0.050 |
Why?
| | Hematoma, Subdural, Chronic | 1 | 2000 | 1 | 0.050 |
Why?
| | Contraceptives, Oral, Hormonal | 1 | 2000 | 5 | 0.050 |
Why?
| | Nipecotic Acids | 3 | 2004 | 7 | 0.050 |
Why?
| | Piracetam | 3 | 2004 | 13 | 0.050 |
Why?
| | Managed Care Programs | 1 | 2000 | 12 | 0.050 |
Why?
| | Folic Acid | 1 | 2000 | 24 | 0.050 |
Why?
| | Electric Stimulation | 1 | 2000 | 87 | 0.050 |
Why?
| | United States | 3 | 2004 | 2539 | 0.050 |
Why?
| | Amobarbital | 1 | 1999 | 3 | 0.050 |
Why?
| | Anesthetics, Intravenous | 1 | 1999 | 11 | 0.050 |
Why?
| | Double-Blind Method | 4 | 2010 | 559 | 0.050 |
Why?
| | Movement Disorders | 3 | 1975 | 150 | 0.050 |
Why?
| | Pregnancy | 1 | 2000 | 457 | 0.040 |
Why?
| | Diet | 1 | 2000 | 202 | 0.040 |
Why?
| | Social Conditions | 1 | 1998 | 1 | 0.040 |
Why?
| | Videotape Recording | 1 | 1998 | 49 | 0.040 |
Why?
| | Economics, Pharmaceutical | 1 | 1997 | 6 | 0.040 |
Why?
| | Clinical Trials as Topic | 3 | 2004 | 378 | 0.040 |
Why?
| | National Health Programs | 1 | 1997 | 5 | 0.040 |
Why?
| | Drugs, Investigational | 1 | 1997 | 11 | 0.040 |
Why?
| | Drug Costs | 1 | 1997 | 18 | 0.040 |
Why?
| | Intraoperative Care | 1 | 1998 | 58 | 0.040 |
Why?
| | Drug Utilization | 1 | 1997 | 27 | 0.040 |
Why?
| | Health Care Reform | 1 | 1997 | 20 | 0.040 |
Why?
| | Breast Feeding | 1 | 2000 | 177 | 0.040 |
Why?
| | Aged, 80 and over | 1 | 2008 | 5234 | 0.040 |
Why?
| | Health Policy | 1 | 1997 | 52 | 0.040 |
Why?
| | Memory | 1 | 1999 | 343 | 0.040 |
Why?
| | Health Services Accessibility | 1 | 1998 | 113 | 0.040 |
Why?
| | Young Adult | 2 | 2016 | 2277 | 0.040 |
Why?
| | Methohexital | 1 | 1995 | 1 | 0.040 |
Why?
| | Magnetoencephalography | 1 | 1995 | 5 | 0.040 |
Why?
| | Pia Mater | 1 | 1995 | 7 | 0.040 |
Why?
| | Speech | 1 | 1995 | 26 | 0.040 |
Why?
| | Morbidity | 1 | 1995 | 71 | 0.040 |
Why?
| | Deanol | 1 | 1975 | 1 | 0.040 |
Why?
| | Ethanolamines | 1 | 1975 | 5 | 0.040 |
Why?
| | Phenylcarbamates | 1 | 1995 | 3 | 0.040 |
Why?
| | Myoclonus | 1 | 1975 | 35 | 0.040 |
Why?
| | Treatment Failure | 1 | 1995 | 187 | 0.030 |
Why?
| | Time Factors | 3 | 1999 | 1902 | 0.030 |
Why?
| | Neuropsychological Tests | 1 | 1999 | 1300 | 0.030 |
Why?
| | Postoperative Period | 1 | 1995 | 295 | 0.030 |
Why?
| | Drug Approval | 2 | 2004 | 31 | 0.030 |
Why?
| | United States Food and Drug Administration | 2 | 2004 | 75 | 0.030 |
Why?
| | Epilepsy, Tonic-Clonic | 1 | 1992 | 9 | 0.030 |
Why?
| | Motor Cortex | 1 | 1992 | 17 | 0.030 |
Why?
| | Evidence-Based Medicine | 2 | 2004 | 239 | 0.030 |
Why?
| | Risk Factors | 2 | 1998 | 2664 | 0.030 |
Why?
| | Age Factors | 3 | 2004 | 943 | 0.030 |
Why?
| | Amphetamines | 1 | 1991 | 1 | 0.030 |
Why?
| | Iodine Radioisotopes | 1 | 1991 | 23 | 0.030 |
Why?
| | Educational Status | 2 | 2011 | 291 | 0.030 |
Why?
| | Sclerosis | 1 | 2011 | 69 | 0.030 |
Why?
| | Age of Onset | 1 | 2011 | 113 | 0.030 |
Why?
| | Acute Disease | 2 | 2004 | 254 | 0.030 |
Why?
| | Administration, Rectal | 2 | 2001 | 6 | 0.020 |
Why?
| | Pilot Projects | 1 | 1992 | 455 | 0.020 |
Why?
| | Diffusion Tensor Imaging | 1 | 2010 | 78 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2011 | 362 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2010 | 281 | 0.020 |
Why?
| | Follow-Up Studies | 2 | 2010 | 2028 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2016 | 3591 | 0.020 |
Why?
| | Memory Disorders | 1 | 2010 | 181 | 0.020 |
Why?
| | Electrodes | 1 | 2008 | 16 | 0.020 |
Why?
| | Neurosurgery | 1 | 1988 | 49 | 0.020 |
Why?
| | Microelectrodes | 1 | 2008 | 41 | 0.020 |
Why?
| | Craniotomy | 1 | 2008 | 29 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2011 | 986 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 1989 | 580 | 0.020 |
Why?
| | Intraoperative Complications | 1 | 2008 | 76 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 2 | 1989 | 891 | 0.020 |
Why?
| | Autopsy | 1 | 2008 | 340 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2008 | 494 | 0.020 |
Why?
| | Cerebral Infarction | 1 | 1987 | 159 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2010 | 1452 | 0.020 |
Why?
| | Inflammation | 1 | 2008 | 360 | 0.020 |
Why?
| | Depression | 1 | 2010 | 516 | 0.020 |
Why?
| | Cytochrome P-450 Enzyme Inhibitors | 1 | 2004 | 2 | 0.020 |
Why?
| | Microsomes, Liver | 1 | 2004 | 4 | 0.020 |
Why?
| | Biotransformation | 1 | 2004 | 9 | 0.020 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2004 | 10 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2004 | 50 | 0.020 |
Why?
| | Isoenzymes | 1 | 2004 | 63 | 0.020 |
Why?
| | Area Under Curve | 1 | 2004 | 79 | 0.020 |
Why?
| | Epilepsy, Absence | 1 | 2004 | 2 | 0.020 |
Why?
| | Controlled Clinical Trials as Topic | 1 | 2004 | 6 | 0.020 |
Why?
| | Evoked Potentials, Visual | 1 | 1984 | 4 | 0.020 |
Why?
| | Occipital Lobe | 1 | 1984 | 14 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2004 | 248 | 0.020 |
Why?
| | Kinetics | 1 | 2004 | 278 | 0.020 |
Why?
| | Drug Resistance | 1 | 2004 | 68 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2004 | 160 | 0.020 |
Why?
| | Psychological Tests | 1 | 1982 | 63 | 0.010 |
Why?
| | Reference Values | 1 | 1982 | 260 | 0.010 |
Why?
| | Vomiting | 1 | 2001 | 15 | 0.010 |
Why?
| | Drug Overdose | 1 | 2001 | 7 | 0.010 |
Why?
| | Otitis Media | 1 | 2001 | 6 | 0.010 |
Why?
| | Atrophy | 2 | 1998 | 108 | 0.010 |
Why?
| | Aged | 5 | 2001 | 10295 | 0.010 |
Why?
| | Disease-Free Survival | 1 | 1998 | 241 | 0.010 |
Why?
| | Self Care | 1 | 1998 | 104 | 0.010 |
Why?
| | Recurrence | 1 | 1998 | 389 | 0.010 |
Why?
| | Phosphenes | 1 | 1976 | 1 | 0.010 |
Why?
| | Optic Neuritis | 1 | 1976 | 2 | 0.010 |
Why?
| | Eye Movements | 1 | 1976 | 26 | 0.010 |
Why?
| | Vision, Ocular | 1 | 1976 | 13 | 0.010 |
Why?
| | Parkinson Disease | 2 | 1975 | 1180 | 0.010 |
Why?
| | Trihexyphenidyl | 1 | 1975 | 5 | 0.010 |
Why?
| | Methysergide | 1 | 1975 | 7 | 0.010 |
Why?
| | Benztropine | 1 | 1975 | 6 | 0.010 |
Why?
| | 5-Hydroxytryptophan | 1 | 1975 | 12 | 0.010 |
Why?
| | Propranolol | 1 | 1975 | 13 | 0.010 |
Why?
| | Guinea Pigs | 1 | 1975 | 67 | 0.010 |
Why?
| | Amantadine | 1 | 1975 | 15 | 0.010 |
Why?
| | Dopamine Antagonists | 1 | 1975 | 14 | 0.010 |
Why?
| | Serotonin Antagonists | 1 | 1975 | 19 | 0.010 |
Why?
| | Amphetamine | 1 | 1975 | 15 | 0.010 |
Why?
| | Serotonin | 1 | 1975 | 43 | 0.010 |
Why?
| | Drug Evaluation | 1 | 1975 | 58 | 0.010 |
Why?
| | Amygdala | 1 | 1995 | 56 | 0.010 |
Why?
| | Paresthesia | 1 | 1994 | 7 | 0.010 |
Why?
| | Hoarseness | 1 | 1994 | 4 | 0.010 |
Why?
| | Tranquilizing Agents | 1 | 1974 | 3 | 0.010 |
Why?
| | Cough | 1 | 1994 | 12 | 0.010 |
Why?
| | Patient Dropouts | 1 | 1994 | 31 | 0.010 |
Why?
| | Electrodes, Implanted | 1 | 1994 | 44 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1975 | 512 | 0.010 |
Why?
| | Dementia | 1 | 1979 | 545 | 0.010 |
Why?
| | Equipment Design | 1 | 1994 | 198 | 0.010 |
Why?
| | Prostheses and Implants | 1 | 1994 | 166 | 0.010 |
Why?
| | Cognition Disorders | 1 | 1979 | 1075 | 0.010 |
Why?
| | Iofetamine | 1 | 1991 | 1 | 0.010 |
Why?
| | Sleep | 1 | 1975 | 357 | 0.010 |
Why?
| | Cerebrovascular Circulation | 1 | 1991 | 58 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 1994 | 1240 | 0.010 |
Why?
| | Glioma | 1 | 1988 | 58 | 0.010 |
Why?
| | Animals | 1 | 1975 | 5312 | 0.000 |
Why?
| | Dominance, Cerebral | 1 | 1984 | 24 | 0.000 |
Why?
| | Photic Stimulation | 1 | 1984 | 53 | 0.000 |
Why?
| | Pattern Recognition, Visual | 1 | 1984 | 35 | 0.000 |
Why?
| | Brain Mapping | 1 | 1984 | 199 | 0.000 |
Why?
| | Multiple Sclerosis | 1 | 1976 | 91 | 0.000 |
Why?
| | Prochlorperazine | 1 | 1974 | 1 | 0.000 |
Why?
| | Chlorpromazine | 1 | 1974 | 13 | 0.000 |
Why?
| | Thioridazine | 1 | 1974 | 9 | 0.000 |
Why?
| | Gastritis | 1 | 1974 | 3 | 0.000 |
Why?
| | Trifluoperazine | 1 | 1974 | 4 | 0.000 |
Why?
| | Psychotic Disorders | 1 | 1974 | 51 | 0.000 |
Why?
| | Anxiety Disorders | 1 | 1974 | 176 | 0.000 |
Why?
|
|
Bergen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|